Recursion operates the Recursion OS, an AI-driven drug discovery platform combining large proprietary biological and chemical datasets, automated wet-lab experimentation, and machine learning models to identify novel targets and design optimized molecules. The platform supports oncology and rare-disease programs.
✓ Best for
Organizations seeking AI-led target discovery and molecule optimization at industrial scale through partnership
Capabilities
Phenomics and multi-omics data generation at scaleAutomated high-throughput cell experimentationMachine learning target identificationMolecule design and optimization